Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices among General Practitioners in Western Australia

Heart Lung and Circulation

Volumn 23, Issue 4, 2014, Pages 309-313

  Bell, Damon A ^a,b   Garton Smith, Jacquie ^a   Vickery, Alistair ^c   Kirke, Andrew B ^d   Pang, Jing ^b   Bates, Timothy R ^a,b   Watts, Gerald F ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Awareness; Familial hypercholesterolaemia; General practitioner; Knowledge; Management practices

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; CLINICAL FEATURE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INHERITANCE; KNOWLEDGE; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING; STRUCTURED QUESTIONNAIRE; ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CHILD; HEALTH CARE DELIVERY; HYPERLIPOPROTEINEMIA TYPE II; INFANT; PRESCHOOL CHILD; PRIMARY HEALTH CARE; QUESTIONNAIRE; THEORETICAL MODEL;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; MALE; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; SURVEYS AND QUESTIONNAIRES;

EID: 84897029732     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.08.005     Document Type: Article

References (24)

1. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004, 160:407-420.
2. Marks D., Thorogood M., Neil H.A.W., Humphries S.E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003, 168:1-14.
3. Soutar A.K., Naoumova R.P. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 2007, 4:214-225.
4. Bender R., Bell D.A., Hooper A.J., Edwards G., Van Bockxmeer F.M., Watts G.F., et al. Screening for familial hypercholesterolaemia. Pathology 2012, 44:122-128.
5. Watts G.F., Sullivan D.R., Poplawski N., van Bockxmeer F., Hamilton-Craig I., Clifton P.M., et al. Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl 2011, 12:221-231.
6. Humphries S.E., Hadfield G. Identifying patients with familial hypercholesterolaemia in primary care. Heart 2008, 94:695-696.
7. Kirke A., Watts G.F., Emery J. Detecting familial hypercholesterolaemia in general practice. Aust Fam Physician 2012, 41:965-968.
8. Qureshi N., Humphries S.E., Seed M., Rowlands P., Minhas R. Identification and management of familial hypercholesterolaemia: what does it mean to primary care?. Br J Gen Pract 2009, 59:773-776.
9. Bell D.A., Hooper A.J., Bender R., McMahon J., Edwards G., van Bockxmeer F., et al. Opportunistic screening for familial hypercholesterolaemia via the community laboratory. Ann Clin Biochem 2012, 49:534-537.
10. Marks D., Wonderling D., Thorogood M., Lambert H., Humphries S.E., Neil H.A. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002, 324:1303.
11. Australian Institute of Health and Welfare Medical workforce 2011. National health workforce series no. 3. Cat. no. HWL 49 2013, AIHW, Canberra.
12. Australian Bureau of Statistics. Australian Social Trends. Health Services: Use and Patient Experience 2011, http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Main+Features20Mar+2011.
13. Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012, 97:3956-3964.
14. Bell D.A., Bender R., Hooper A.J., McMahon J., Edwards G., van Bockxmeer F.M., et al. Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia. Clin Chim Acta 2013, 10.1016/j.cca.2013.03.027.
15. Gray J., Jaiyeola A., Whiting M., Modell M., Wierzbicki A.S. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2008, 94:754-758.
16. Watts G.F., Juniper A., van Bockxmeer F., Ademi Z., Liew D., O'Leary P. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations. Int J Evid Based Healthc 2012, 10:211-221.
17. Hooper A.J., Nguyen L.T., Burnett J.R., Bates T.R., Bell D.A., Redgrave T.G., et al. Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis 2012, 224:430-434.
18. Britt H.M.G., Henderson J., Charles J., Valenti L., Harrison C., Bayram C., et al. General practice activity in Australia 2011-12. General practice series no. 31 2012, Sydney University Press, Sydney.
19. Simons L.A., Ortiz M., Calcino G. Long term persistence with statin therapy - experience in Australia 2006-2010. Aust Fam Physician 2011, 40:319-322.
20. Simons L.A., Levis G., Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 1996, 164:208-211.
21. Bates T.R., Connaughton V.M., Watts G.F. Non-adherence to statin therapy: a major challenge for preventive cardiology. Exp Opin Pharmacother 2009, 10:2973-2985.
22. Umans-Eckenhausen M.A., Defesche J.C., van Dam M.J., Kastelein J.J. Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. Arch Intern Med 2003, 163:65-68.
23. Bates T.R., Poulter E.B., van Bockxmeer F.M., Watts G. Family history: the neglected risk factor in disease prevention. Med J Aust 2010, 193:429-430.
24. Qureshi N., Armstrong S., Dhiman P., Saukko P., Middlemass J., Evans P.H., et al. Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Ann Intern Med 2012, 156:253-262.